biphenylWhat was measured
Measured, with no finding
72 endpoints
Show what was measuredHide what was measured
PCB reference values in human blood
The PCBs RVs resulted between 1.2 e 8.28 microg/L for males and between 2.69 e 5.17 microg/L for females the general range varied from 0.9 to 56 microg/L
PMID 15134393 · one of two readings recorded this
PCB reference values in human blood
The PCBs RVs resulted between 1.2 e 8.28 microg/L for males and between 2.69 e 5.17 microg/L for females the general range varied from 0.9 to 56 microg/L
PMID 15134393 · one of two readings recorded this
PCB reference values in human blood
The PCBs RVs resulted between 1.2 e 8.28 microg/L for males and between 2.69 e 5.17 microg/L for females the general range varied from 0.9 to 56 microg/L
PMID 15134393 · one of two readings recorded this
reference values for blood PCB concentration
1.2-8.28 microg/L (males); 2.69-5.17 microg/L (females); overall range 0.9-56 microg/L
The PCBs RVs resulted between 1.2 e 8.28 microg/L for males and between 2.69 e 5.17 microg/L for females the general range varied from 0.9 to 56 microg/L.
PMID 15134393 · one of two readings recorded this
carcinogenicity and noncancer health hazards of oral biphenyl exposure (male rat urinary bladder tumors, female mouse liver tumors, kidney toxicity), narrative synthesis of experimental animal bioassays and mechanistic studies for EPA IRIS
increases
Not recorded as a finding: a review that discusses its trials without pooling them
The available health effects data for biphenyl provides suggestive evidence for carcinogenicity in humans, based on increased incidences of male rat urinary bladder tumors at high exposure levels and on female mouse liver tumors.
PMID 26529796 · one of two readings recorded this
Carcinogenicity (male rat urinary bladder tumors, female mouse liver tumors) and kidney toxicity from oral biphenyl exposure, reviewed across experimental animal bioassays and mechanistic studies
increases
Not recorded as a finding: a review that discusses its trials without pooling them
The available health effects data for biphenyl provides suggestive evidence for carcinogenicity in humans, based on increased incidences of male rat urinary bladder tumors at high exposure levels and on female mouse liver tumors.
PMID 26529796 · one of two readings recorded this
liver tumor incidence (hepatocellular adenoma/carcinoma), female BDF1 mice
increases
Exposure to biphenyl in the diet for 2 years was associated with a statistically significant dose-related increase in the incidence of liver tumors (hepatocellular adenomas or carcinomas) in female BDF1 mice (Table 3).
PMID 26529796 · one of two readings recorded this
renal toxicity (mineralization, necrosis, hyperplasia)
increases
Kidney toxicity is also a potential human health hazard of biphenyl exposure.
PMID 26529796 · one of two readings recorded this
urinary bladder tumor incidence (transitional cell papilloma/carcinoma), male F344 rats
increases, 31/50 papilloma or carcinoma combined at high dose vs 0/50 controls, n = 50
A dose-related increase in transitional cell papilloma and carcinoma of the urinary bladder was reported in male F344 rats exposed to biphenyl in the diet for 2 years (Table 2).
PMID 26529796 · one of two readings recorded this
breast cancer risk, Group II and Group III PCB congeners
increases, OR = 1.23 (95% CI 1.08-1.40) for Group II; OR = 1.25 (95% CI 1.09-1.43) for Group III
The pooled ORs were 1.23 (95%CI: 1.08–1.40) for group II and 1.25 (95%CI: 1.09–1.43) for group III, respectively.
PMID 26555153 · one of two readings recorded this
breast cancer risk, total PCB exposure (highest vs lowest category)
no effect, OR = 1.09 (95% CI: 0.97-1.22)
Overall, the summary OR of total PCBs was slightly elevated but not statistically significant and heterogeneity was relatively high (OR = 1.09, 95%CI: 0.97–1.22, I2 = 55.4%).
PMID 26555153 · one of two readings recorded this
anti-fungal activity
increases, Some of the compounds have shown significant pharmacological properties.
Some of the compounds have shown significant pharmacological properties.
PMID 28083853 · both readings recorded this
anti-HIV-1 reverse transcriptase inhibition activity
Anti-HIV activity using anti-HIV-1 reverse transcriptase and syncytium inhibition assays, and cytotoxic activity against a panel of cultured mammalian cancer cell lines of isolated compounds were investigated.
PMID 29247893 · one of two readings recorded this
cytotoxic activity against cultured mammalian cancer cell lines
Anti-HIV activity using anti-HIV-1 reverse transcriptase and syncytium inhibition assays, and cytotoxic activity against a panel of cultured mammalian cancer cell lines of isolated compounds were investigated.
PMID 29247893 · one of two readings recorded this
urinary estrone-3-glucuronide, pregnanediol-3-glucuronide and FSH levels across the menstrual cycle
decreases, n = 70
We observed that high (>3.0 parts per billion [ppb]) and medium (>1.0-3.0 ppb) PBB exposure were associated with lower E13G levels across the menstrual cycle and lower FSH levels during the follicular phase, compared with low PBB exposure (≤1.0 ppb).
PMID 31180930 · one of two readings recorded this
urinary reproductive hormone levels (estrone-3-glucuronide, pregnanediol-3-glucuronide, FSH) across the menstrual cycle
decreases, n = 70
Not recorded as a finding: the trial gave a chemically different species
We observed that high (>3.0 parts per billion [ppb]) and medium (>1.0-3.0 ppb) PBB exposure were associated with lower E13G levels across the menstrual cycle and lower FSH levels during the follicular phase, compared with low PBB exposure (≤1.0 ppb).
PMID 31180930 · one of two readings recorded this
Association between polychlorinated biphenyl exposure and breast cancer risk, reviewed across epidemiologic studies
no effect
Not recorded as a finding: the trial gave a chemically different species
However, the results of most epidemiologic studies do not support an association between PCB exposure and breast cancer risk.
PMID 31521536 · one of two readings recorded this
breast cancer risk
no effect
However, the results of most epidemiologic studies do not support an association between PCB exposure and breast cancer risk.
PMID 31521536 · one of two readings recorded this
cardiac output
increases
In vivo, compound 15a demonstrated a dose-dependent improvement in the cardiac output in male Sprague Dawley rats with no significant changes in either mean arterial blood pressure or heart rate
PMID 31724863 · one of two readings recorded this
in vitro APJ receptor potency
no effect
Compound 15a demonstrated comparable in vitro potency to apelin-13, the endogenous peptidic ligand for the APJ receptor
PMID 31724863 · one of two readings recorded this
mean arterial blood pressure and heart rate
no effect
In vivo, compound 15a demonstrated a dose-dependent improvement in the cardiac output in male Sprague Dawley rats with no significant changes in either mean arterial blood pressure or heart rate
PMID 31724863 · one of two readings recorded this
offspring birthweight (lowest quartile) and gestational age by paternal PBB/PCB tertile
increases, aRR = 2.06 (95% CI: 1.12, 3.79), upper paternal PBB tertile vs lower tertile, n = 336
Not recorded as a finding: the trial gave a chemically different species
Lowest quartile offspring birthweight was associated with monotonic increased adjusted risk ratios (aRR) in the middle (aRR=1.67, 95% CI: 0.93, 2.99) and upper tertiles (aRR=2.06, 95% CI = 1.12, 3.79) for PBB (Table 3).
PMID 36041536 · one of two readings recorded this
offspring birthweight, lowest quartile
increases, aRR = 1.67 (95% CI: 0.93, 2.99) middle tertile; aRR = 2.06 (95% CI: 1.12, 3.79) upper tertile, paternal PBB, n = 336
Lowest quartile offspring birthweight was associated with monotonic increased adjusted risk ratios (aRR) in the middle (aRR=1.67, 95% CI: 0.93, 2.99) and upper tertiles (aRR=2.06, 95% CI = 1.12, 3.79) for PBB (Table 3).
PMID 36041536 · one of two readings recorded this
offspring preterm birth / gestational age
no effect
Preterm gestational age was not associated with increasing paternal PBB or PCB levels in the log-risk models (Table 4).
PMID 36041536 · one of two readings recorded this
semen quality decline, evidence rating
decreases
We found robust evidence that PCB-118 and -169 were linked to declines in semen quality
PMID 36217156 · one of two readings recorded this
semen quality decline, evidence rating
decreases
Evidence for adverse effects of PCB-126, -132, -149, and -153 was moderate, whereas for PCB-77 it was slight and for PCB-180 indeterminate
PMID 36217156 · one of two readings recorded this
semen quality in experimental animal studies
decreases
Our review of experimental animal studies found that treatments with PCBs affected semen quality, in most cases adversely
PMID 36217156 · one of two readings recorded this
high priority studies identified by DoCTER clustering and ML from 2015 search
n = 11177
Collectively, clustering and ML approaches using DoCTER identified 11,177 studies from the initial literature search conducted in 2015 as high priority studies for manual review
PMID 36580985 · one of two readings recorded this
human and nonhuman mammalian studies evaluated for health endpoints
n = 1590
A total of 953 human studies and 637 nonhuman mammalian studies were evaluated for health endpoints and exposure to PCBs
PMID 36580985 · one of two readings recorded this
human studies of PCB exposure and allergy or asthma
n = 43
Forty-three human studies evaluated PCB exposure in relation to allergy or asthma
PMID 36580985 · one of two readings recorded this
male reproductive organ size/weight studies
n = 72
Male reproductive organ size/weight was measured in only eight human studies but 72 nonhuman mammalian studies
PMID 36580985 · one of two readings recorded this
nonhuman mammalian studies of renal biomarkers
n = 28
Only four human studies evaluated frank renal disease or diabetic nephropathy; the majority instead measured biomarkers of renal function
PMID 36580985 · one of two readings recorded this
proportion of nonprioritized studies relevant to PECO criteria
Review of a randomly selected subset of nonprioritized studies demonstrated that less than 10% of nonprioritized studies were relevant based on PECO criteria
PMID 36580985 · one of two readings recorded this
seed references designated from studies meeting PECO criteria
n = 483
Briefly, 483 studies selected as having met the PECO criteria for inclusion in this review (Table 1) were designated as seed references
PMID 36580985 · one of two readings recorded this
studies added by yearly literature search updates 2016 to 2021
n = 11390
Yearly literature search updates were conducted from 2016 to 2021, yielding between 1756 and 2402 unique studies per year, which added 11,390 studies
PMID 36580985 · one of two readings recorded this
studies identified by 2015 initial literature search after duplicate removal
n = 50309
After duplicate removal, 50,309 studies were identified from the initial literature search conducted in 2015
PMID 36580985 · one of two readings recorded this
studies identified through database searching after duplicate removal, 2015-2021
n = 61699
Thus, 61,699 studies were identified through database searching after duplicate removal
PMID 36580985 · one of two readings recorded this
studies included in literature summary tables
n = 1586
After full-text review and categorization, 1586 studies were included in literature summary tables organized by organ/system
PMID 36580985 · one of two readings recorded this
studies manually reviewed in 2016 updates
n = 1818
In 2016, all 1818 unique studies were manually reviewed
PMID 36580985 · one of two readings recorded this
studies manually reviewed (title and abstract) from database searches
n = 17037
Thus, 17,037 (27.6%) of the 61,699 studies retrieved through literature searches were manually reviewed
PMID 36580985 · one of two readings recorded this
studies of response to immune challenge
n = 28
Response to immune challenge was evaluated in seven human studies (after vaccination) and 28 nonhuman mammalian studies
PMID 36580985 · one of two readings recorded this
studies prioritized with SWIFT-Active Screener and manually screened from 2017-2021 retrieval
n = 4042
Of the 9572 studies retrieved in 2017–2021, 4042 studies were prioritized using SWIFT-Active Screener and were manually screened
PMID 36580985 · one of two readings recorded this
studies subjected to full-text review
n = 3889
Of these, 3889 were identified as potentially relevant and subjected to full-text review and categorization by health endpoint
PMID 36580985 · one of two readings recorded this
total studies in manual review including seed and expert-identified studies
n = 17937
The manual review thus included 17,937 studies
PMID 36580985 · one of two readings recorded this
maximum response relative to orexin-A, OX1 receptor, most potent azulene-based compound
The most potent azulene-based compound was identified as an OX1 orexin receptor agonist (pEC50 = 5.79 ± 0.07, maximum response = 81 ± 8% (s.e.m. of five independent experiments) of the maximum response to orexin-A in Ca2+ elevation assay)
PMID 37209639 · one of two readings recorded this
articles reporting PCB half-lives in humans
n = 26
In total, 26 articles were found to report half-lives in humans, with the majority of data coming from studies performed in North America on individuals suspected to have been exposed to PCBs
PMID 37832892 · one of two readings recorded this
PCB half-life by degree of chlorination
decreases
Less chlorinated PCBs generally have shorter half-lives than more chlorinated PCBs
PMID 37832892 · one of two readings recorded this
PCB half-life, occupationally exposed versus general population
decreases
We also identified significantly shorter half-lives for some PCBs in occupationally exposed individuals compared to results reported from the general population
PMID 37832892 · one of two readings recorded this
NLRP3 inflammasome inhibition (binding affinity, IC50) and anti-inflammatory activity in a mouse acute peritonitis model
decreases, IC50 = 0.57 μM; KD = 1.15 μM
Not recorded as a finding: the trial gave a chemically different species
The representative compound H28 was identified as potent and specific NLRP3 inflammasome inhibitor with IC50 values of 0.57 μM.
PMID 38492493 · one of two readings recorded this
NLRP3 inflammasome pathway activation, mouse acute peritonitis model
decreases
The results in a mouse acute peritonitis model revealed that H28 effectively inhibit the NLRP3 inflammasome pathway, demonstrating their anti-inflammatory properties.
PMID 38492493 · one of two readings recorded this
NLRP3 inflammasome pathway inhibition in acute peritonitis
decreases
The results in a mouse acute peritonitis model revealed that H28 effectively inhibit the NLRP3 inflammasome pathway, demonstrating their anti-inflammatory properties.
PMID 38492493 · one of two readings recorded this
NLRP3 protein binding (KD) and inflammasome assembly/activation inhibition by biphenyl-sulfonamide compound H28, in vitro and in a mouse acute peritonitis model
decreases
Not recorded as a finding: the trial gave a chemically different species
Preliminary mechanistic studies have revealed that compound H28 exhibits direct binding to the NLRP3 protein (KD: 1.15 μM), effectively inhibiting the assembly and activation of the NLRP3 inflammasome.
PMID 38492493 · one of two readings recorded this
diabetes mellitus
increases, OR = 3.593 (95% CI 2.566, 5.031)
The pooled OR showed that PCB congener exposure among the population was highly associated with the risk of DM (OR = 3.593, 95% CI 2.566, 5.031).
PMID 39095444 · one of two readings recorded this
hypertension
no effect, OR = 1.335 (95% CI 0.902, 1.976)
However, the pooled OR showed a lack of association between PCB congener exposure and the risk of HTN (OR = 1.335, 95% CI 0.902, 1.976).
PMID 39095444 · one of two readings recorded this
hypertriglyceridaemia
no effect, OR = 1.611 (95% CI 0.981, 2.643)
The pooled OR was 1.611 (95% CI 0.981, 2.643), suggesting no association between PCB congener exposure and the risk of HTG.
PMID 39095444 · one of two readings recorded this
low HDL cholesterol
decreases, OR = 0.34 (95% CI 0.092, 1.258)
However, the pooled OR (0.34, 95% CI 0.092, 1.258) showed that there was a negative association between PCB congener exposure and the risk of having low HDL.
PMID 39095444 · one of two readings recorded this
metabolic syndrome, dioxin exposure
increases, OR = 2.742 (95% CI 1.936, 3.883)
The pooled OR described minimal association (OR = 2.742, 95% CI 1.936, 3.883).
PMID 39095444 · one of two readings recorded this
metabolic syndrome, PCB exposure
no effect, OR = 1.162 (95% CI 0.994, 1.357)
The pooled OR showed a limited association (OR = 1.162, 95% CI 0.994, 1.357) that was statistically insignificant (P > 0.05).
PMID 39095444 · one of two readings recorded this
obesity (BMI > 30 kg/m2)
no effect, OR = 1.875 (95% CI 0.883, 3.979)
The pooled effects estimated from all three studies showed no statistical significance (P = 0.102, random effect) between the association of PCB congener exposure and an increase in BMI.
PMID 39095444 · one of two readings recorded this
Ectopic lesion growth in a mouse endometriosis model and ERβ-mediated epigenetic regulation following PCB-126 exposure
increases
Not recorded as a finding: the trial gave a chemically different species
In a mouse model of endometriosis, PCB-126 exposure significantly promoted the growth of ectopic lesions by activating the Steroid Receptor Coactivator-1 (SRC-1) isoform/Matrix Metalloproteinase-9 (MMP9)/Estrogen Receptor-β (ERβ) axis, a critical pathway driving disease progression.
PMID 40951281 · one of two readings recorded this
endometriotic ectopic lesion volume and ERβ/AXL/GAS6/DNMT3A pathway activation in mouse and human endometriotic tissue
increases
Not recorded as a finding: the trial gave a chemically different species
Compared to vehicle-treated mice, PCB126 exposure significantly increased the volume of ectopic lesions.
PMID 40951281 · one of two readings recorded this
endometriotic ectopic lesion volume, AXL inhibitor effect
decreases
BMS-777607 treatment significantly reduced the volume of endometriotic lesions in PCB126-exposed mice compared to the vehicle-treated group (and).
PMID 40951281 · one of two readings recorded this
endometriotic ectopic lesion volume
increases
Compared to vehicle-treated mice, PCB126 exposure significantly increased the volume of ectopic lesions.
PMID 40951281 · one of two readings recorded this
pregnancy loss and birth defects
unclear
There were fewer human studies of pregnancy loss or birth defects, and the evidence was generally less consistent for these outcomes
PMID 41702292 · one of two readings recorded this
relevant studies identified
n = 154
We identified n = 154 relevant studies, the majority of which focused on birth weight or other aspects of early life size and growth
PMID 41702292 · one of two readings recorded this
size at birth
decreases
These studies often reported decrements in size at birth associated with higher maternal measures of exposure, although the evidence was less clear for size and growth in later childhood
PMID 41702292 · one of two readings recorded this
Inhibition of LPS-induced nitric oxide release in BV2 microglial cells by six new biphenyl derivatives isolated from Garcinia yunnanensis
decreases
Not recorded as a finding: the trial gave a chemically different species
Additionally, all six new compounds were evaluated for their ability to inhibit LPS-induced nitric oxide (NO) release in BV2 microglial cells, demonstrating moderate anti-inflammatory activity.
PMID 42055094 · one of two readings recorded this
LPS-induced nitric oxide (NO) release
decreases
Additionally, all six new compounds were evaluated for their ability to inhibit LPS-induced nitric oxide (NO) release in BV2 microglial cells, demonstrating moderate anti-inflammatory activity.
PMID 42055094 · one of two readings recorded this
LPS-induced nitric oxide release in BV2 microglial cells
decreases
Additionally, all six new compounds were evaluated for their ability to inhibit LPS-induced nitric oxide (NO) release in BV2 microglial cells, demonstrating moderate anti-inflammatory activity.
PMID 42055094 · one of two readings recorded this
LPS-induced nitric oxide release inhibition in BV2 microglial cells
decreases
Not recorded as a finding: the trial gave a chemically different species
Additionally, all six new compounds were evaluated for their ability to inhibit LPS-induced nitric oxide (NO) release in BV2 microglial cells, demonstrating moderate anti-inflammatory activity.
PMID 42055094 · one of two readings recorded this
blood/tissue PCB congener concentration after known exposure incidents vs general-population controls
increases, 6.9 ppb (Yusho patients) vs 1.6 ppb (Fukuoka controls), n = 11
Figure 1 graphically depicts mean PCB serum levels for the selected tetra through heptachlorinated PCBs in blood of 11 patients as compared to the control blood from the general population.
PMID 8187704 · one of two readings recorded this
blood/tissue PCB congener concentrations in exposed cohorts (Yusho patients, Guam workers, firefighters, exposed children, Vietnam veterans) versus controls
increases, 6.9 ppb (Yusho patients) vs 1.6 ppb (Fukuoka controls), n = 11
Not recorded as a finding: the trial gave a chemically different species
Figure 1 graphically depicts mean PCB serum levels for the selected tetra through heptachlorinated PCBs in blood of 11 patients as compared to the control blood from the general population.
PMID 8187704 · one of two readings recorded this